Restart Life Sciences Corp. (NMLSF)
OTCMKTS · Delayed Price · Currency is USD
0.0676
-0.0028 (-3.96%)
Jul 16, 2025, 4:00 PM EDT
Restart Life Sciences Company Description
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide.
It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome.
The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024.
Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Restart Life Sciences Corp.
| Country | Canada |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Steve Loutskou |
Contact Details
Address: 700-838 West Hasting Street Vancouver, British Columbia V6C 0A6 Canada | |
| Phone | 778 819 0244 |
| Website | restartlife.co |
Stock Details
| Ticker Symbol | NMLSF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA66980V1067 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Steve Loutskou | President, Chief Executive Officer and Executive Chairman |
| Rebecca Lynn Hudson C.A., C.P.A. | Chief Financial Officer |
| Dr. Aylia Mohammadi B.Sc., M.Sc., Ph.D. | President and Chief Scientific Officer of Nova Mentis Biotech Corporate |
| Kelly Pladson | Corporate Secretary |